France
· Delayed Price · Currency is EUR Global Bioenergies Statistics
Total Valuation
Global Bioenergies has a market cap or net worth of EUR 21.03 million. The enterprise value is 19.01 million.
| Market Cap | 21.03M |
| Enterprise Value | 19.01M |
Important Dates
The next estimated earnings date is Tuesday, February 25, 2025.
| Earnings Date | Feb 25, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
Global Bioenergies has 18.13 million shares outstanding. The number of shares has increased by 11.98% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 18.13M |
| Shares Change (YoY) | +11.98% |
| Shares Change (QoQ) | +1.55% |
| Owned by Insiders (%) | 2.58% |
| Owned by Institutions (%) | 3.65% |
| Float | 15.21M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 44.04 |
| PB Ratio | 4.55 |
| P/TBV Ratio | 4.76 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -2.58 |
| EV / Sales | 39.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -4.05 |
Financial Position
The company has a current ratio of 2.06, with a Debt / Equity ratio of 1.23.
| Current Ratio | 2.06 |
| Quick Ratio | 1.67 |
| Debt / Equity | 1.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | -1.21 |
| Interest Coverage | -52.50 |
Financial Efficiency
Return on equity (ROE) is -102.78% and return on invested capital (ROIC) is -41.40%.
| Return on Equity (ROE) | -102.78% |
| Return on Assets (ROA) | -30.73% |
| Return on Capital (ROIC) | -41.40% |
| Revenue Per Employee | 11,047 |
| Profits Per Employee | -167,303 |
| Employee Count | 46 |
| Asset Turnover | 0.03 |
| Inventory Turnover | 0.52 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -39.09% in the last 52 weeks. The beta is 1.65, so Global Bioenergies's price volatility has been higher than the market average.
| Beta (5Y) | 1.65 |
| 52-Week Price Change | -39.09% |
| 50-Day Moving Average | 0.93 |
| 200-Day Moving Average | 1.46 |
| Relative Strength Index (RSI) | 57.49 |
| Average Volume (20 Days) | 45,954 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Global Bioenergies had revenue of EUR 486,058 and -7.36 million in losses. Loss per share was -0.40.
| Revenue | 486,058 |
| Gross Profit | -155,903 |
| Operating Income | -8.67M |
| Pretax Income | -8.55M |
| Net Income | -7.36M |
| EBITDA | -5.88M |
| EBIT | -8.67M |
| Loss Per Share | -0.40 |
Balance Sheet
The company has 7.69 million in cash and 5.67 million in debt, giving a net cash position of 2.01 million or 0.11 per share.
| Cash & Cash Equivalents | 7.69M |
| Total Debt | 5.67M |
| Net Cash | 2.01M |
| Net Cash Per Share | 0.11 |
| Equity (Book Value) | 4.62M |
| Book Value Per Share | 0.26 |
| Working Capital | 6.19M |
Cash Flow
In the last 12 months, operating cash flow was -4.05 million and capital expenditures -646,553, giving a free cash flow of -4.70 million.
| Operating Cash Flow | -4.05M |
| Capital Expenditures | -646,553 |
| Free Cash Flow | -4.70M |
| FCF Per Share | -0.26 |
Margins
| Gross Margin | -32.07% |
| Operating Margin | -1,782.73% |
| Pretax Margin | -1,758.71% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Global Bioenergies does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.98% |
| Shareholder Yield | -11.98% |
| Earnings Yield | -34.39% |
| FCF Yield | -22.33% |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
Global Bioenergies has an Altman Z-Score of 0.8. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.8 |
| Piotroski F-Score | n/a |